384 related articles for article (PubMed ID: 25595209)
1. Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.
Lanas A; Gargallo CJ
J Gastroenterol; 2015 Jun; 50(6):626-37. PubMed ID: 25595209
[TBL] [Abstract][Full Text] [Related]
2. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
3. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
Valkhoff VE; Sturkenboom MC; Kuipers EJ
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
Iijima K; Shimosegawa T
Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687
[TBL] [Abstract][Full Text] [Related]
6. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
Nardulli G; Lanas A
Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
[TBL] [Abstract][Full Text] [Related]
7. Anti-platelet therapy and managing ulcer risk.
Chan FK
J Gastroenterol Hepatol; 2012 Feb; 27(2):195-9. PubMed ID: 22142030
[TBL] [Abstract][Full Text] [Related]
8. Management of high-risk patients on non-steroidal anti-inflammatory drugs or aspirin.
Chan FK
Drugs; 2006; 66 Suppl 1():23-8; discussion 29-33. PubMed ID: 16869345
[TBL] [Abstract][Full Text] [Related]
9. [Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].
Casado-Arroyo R; Muñoz-Villalenguas M; Lanas Arbeloa A
Gastroenterol Hepatol; 2011; 34(7):478-91. PubMed ID: 21684042
[TBL] [Abstract][Full Text] [Related]
10. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents].
Bretagne JF
Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327
[TBL] [Abstract][Full Text] [Related]
11. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
Lanas A; Scheiman J
Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
[TBL] [Abstract][Full Text] [Related]
12. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
14. [The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage].
Bae SE; Kim SE; Jung SA; Yoon SY; Shim KN; Jung HK; Kim TH; Yoo K; Moon IH
Korean J Gastroenterol; 2011 Apr; 57(4):213-20. PubMed ID: 21519174
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
Lanas A
Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice.
Leung Ki EL; Chan FK
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):163-72. PubMed ID: 22542154
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin.
Hsu PI; Tsai TJ
Curr Pharm Des; 2015; 21(35):5049-55. PubMed ID: 26369688
[TBL] [Abstract][Full Text] [Related]
18. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
19. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.
Peura DA; Wilcox CM
Postgrad Med; 2014 Jan; 126(1):87-96. PubMed ID: 24393755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
